Actress Glynis Barber is AM's guest tonight ahead of her appearance in Death on the Nile. Music from The B-52s, Muse, Mr ...

Ralph re-visits Van Morrison's legendary early seventies live recording "It's Too Late To Stop Now" for this week's Classic Live Album It's All Over Now Baby Blue ...

The ASX closes down 1.94%, wiping ~$64 billion off the Australian sharemarket in a single session on March 4, 2026.

Back home, 10 of 11 ASX sectors were in the red this mornig, with only technology managing to stay positive. The mining ...

Netflix's reality dating series "Love Is Blind" is introducing dozens of single men and women from Ohio for the 10th season. To start, men and women go on literal blind dates, having conversations in ...

VectorY Therapeutics Receives FDA Fast Track Designation for VTx-002, a First-in-Class Vectorized Antibody Targeting Underlying Disease Biology in ALS ~ Designation enables an enhanced development ...

TARA-002 demonstrates high complete response rates in BCG-naïve NMIBC patients, with 72% achieving CR and 50% maintaining it at 12 months. The treatment involves six weekly bladder instillations, ...

If you thought the Urus owed its existence to Lamborghini’s wild LM002, think again. The pickup-bed “Rambo Lambo” might be the official factory-produced dad, but this one-off LM002 wagon is arguably ...

Shares of workplace travel software company Navan swooned 20% Thursday from their initial public offering price, closing at $20 a share. Between the company’s earlier sheen and its offer price, Navan ...

Take on the role of Annie, a low level employee of the SCP Foundation, A covert organization meant to secure and contain anomalous entities and protect the general public. Why has an organization with ...

New Delhi [India], October 10 (ANI): Nationalist Congress Party (NCP) leader Sharadchandra Pawar (NCP-SCP), Nilesh Lanke, met suspended advocate Rakesh Kishore, who had attempted to hurl a shoe at ...

Completion of Phase 1b safety run-in and determination of recommended Phase 2 dose (RP2D) enables advancement into expansion cohorts for both hormone receptor-positive, HER2-negative (HR+/HER2−) and ...